EICHORCondition: Lumbar Disc Herniation · Sponsor: Seikagaku Corporation
This study is to evaluate the effectiveness of a single-dose intervertebral disc injection of SI-6603 in subjects with lumbar disc herniation (LDH)
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Delta Clinical Research | Mobile, Alabama, United States | — |
| Pain Medicine Associates, Inc. | Fountain Valley, California, United States | — |
| University of California San Diego - Center for Pain Medicine | La Jolla, California, United States | — |
| The Helm Center for Pain Management | Laguna Woods, California, United States | — |
| The Anand Spine Group | Los Angeles, California, United States | — |
| VA Greater Los Angeles Healthcare System | Los Angeles, California, United States | — |
| Samaritan Center for Medical Research | Los Gatos, California, United States | — |
| UC Davis Spine Center | Sacramento, California, United States | — |
| Source Healthcare | Santa Monica, California, United States | — |
| Boulder Neurosurgical Associates | Boulder, Colorado, United States | — |
| DBPS Research, LLC | Greenwood Village, Colorado, United States | — |
| International Spine, Pain, and Performance Center | Washington D.C., District of Columbia, United States | — |
+ 55 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03607838